Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Autosomal Recessive Chronic Granulomatous Disease

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Autosomal Recessive Chronic Granulomatous Disease in 1 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vago, T1
Norbiato, G1
Baldi, G1
Chebat, E1
Bertora, P1
Bevilacqua, M1

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Autosomal Recessive Chronic Granulomatous Disease

ArticleYear
Respiratory-burst stimulants desensitize beta-2 adrenoceptors on human polymorphonuclear leukocytes.
    International journal of tissue reactions, 1990, Volume: 12, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adrenergic beta-Antagonists; Binding, Competitive; Gr

1990